- provide clear guidelines for effective working models and tools for HTA collaboration at EU level
- prevent duplication of work between national agencies and promote sharing and reuse of HTA information, particularly regarding relative safety and efficacy/effectiveness
- spread expertise, for the benefit of all EU countries
- strengthen evaluations carried out by EU countries
- develop transparent governance tools, notably vis-à-vis stakeholders
- produce a number of joint scientific assessments on interventions, medical devices and pharmaceuticals.Denmark (represented by the National Board of Health), through the secretariat of the EUnetHTA collaboration project.
Denmark (represented by the National Board of Health), serving as the secretariat of the EUnetHTA collaboration project.
Two annual meetings – both held in May – play a central role in governing the project:
- annual meeting of the stakeholder forum (consisting of European umbrella organisations representing industry, patients/consumers, health professionals and health financing
- joint action plenary assembly (attended by all participating HTA agencies, and observers from the Stakeholder Forum).
Details of joint action meetings
The Executive Agency for Health and Consumers implements the EU health programme, manages the selected projects and works on the joint action mechanism.